XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Research and development $ 27,786 $ 15,726
General and administrative 9,209 8,424
Total operating expenses 36,995 24,150
Loss from operations (36,995) (24,150)
Other income (expense):    
Interest and investment income 3,346 4,241
Other expense, net (60) (19)
Total other income, net 3,286 4,222
Net loss $ (33,709) $ (19,928)
Net loss per share attributable to common shareholders - basic $ (0.58) $ (0.38)
Net loss per share attributable to common shareholders - diluted $ (0.58) $ (0.38)
Weighted-average common shares outstanding used in net loss per share - basic 58,005,312 52,294,765
Weighted-average common shares outstanding used in net loss per share - diluted 58,005,312 52,294,765